There is no requirement for routine drug level monitoring, as therapeutic drug monitoring is not clinically indicated or available for tirzepatide
When you look at our momentum along with the synergistic opportunities that lie in front of us with Teladoc, this merger is a no brainer, says Burke
In summary: Klow and Glow share 75% of their composition
Stop doing something harmful or react quickly to something harmful
Antioxidants like glutathione help protect the body from oxidative damage caused by free radicals, something that happens every day
Today's approval provides an important new option for these patients and supports our strategy to acquire assets with validated targets that could meaningfully improve standards of care, said Tony Wood, Chief Scientific Officer at GSK, in the press release